Bradford Hoppe, M.D.

Bradford Hoppe, M.D., M.P.H. - Research & Publications

(904) 588-1800

Request an Appointment

Publications

PTV margin analysis for prostate patients treated with initial pelvic nodal IMRT and prostate proton boost
Physics in Medicine and Biology
2019

Stereotactic Ablative Body Radiotherapy for Primary Non-Small-Cell Lung Cancer: Achieving Local Control with a Lower Biologically Effective Dose.
Cancer Investigation
2018

Report From the Swog Radiation Oncology Committee: Research Objectives Workshop 2017
Clinical Cancer Research
2018

Rationale and Early Outcomes for the Management of Thymoma With Proton Therapy
Translational Lung Cancer Research
2018

Proton therapy for pediatric malignancies: Fact, figures and costs. A joint consensus statement from the pediatric subcommittee of PTCOG, PROS and EPTN.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
2018

PROTON THERAPY FOR ADULTS WITH MEDIASTINAL LYMPHOMAS: THE INTERNATIONAL LYMPHOMA RADIATION ONCOLOGY GROUP (ILROG) GUIDELINES.
Blood
2018

Staging Evaluation and Response Criteria Harmonization (Search) for Childhood, Adolescent and Young Adult Hodgkin Lymphoma (Cayahl): Methodology Statement

2017

Sperm Preservation and Neutron Contamination Following Proton Therapy for Prostate Cancer Study
Acta Oncologica
2017

Optimal Therapy for Early-Stage Hodgkin's Lymphoma: Risk Adapting, Response Adapting, and Role of Radiotherapy
Current Oncology Reports
2017

Integral Dose for Photon and Proton Hodgkin Lymphoma Radiotherapy

2017

Five-Year Outcomes From a Prospective Trial of Image-Guided Accelerated Hypofractionated Proton Therapy for Prostate Cancer
Acta Oncologica
2017

Consolidative Proton Therapy After Chemotherapy for Patients With Hodgkin Lymphoma
Annals of Oncology
2017

Proton Therapy for Pediatric Hodgkin Lymphoma

2016

Patient-Reported Quality of Life in Men with Transurethral Resection of the Prostate Undergoing Proton Therapy for Management of Prostate Cancer.
International journal of particle therapy
2016

Does Race Influence Health-Related Quality of Life and Toxicity Following Proton Therapy for Prostate Cancer?
American Journal of Clinical Oncology-Cancer Clinical Trials
2016

Acr Appropriateness Criteria (R) Hodgkin Lymphoma-Unfavorable Clinical Stage I and II
American Journal of Clinical Oncology-Cancer Clinical Trials
2016

A Phase 2 Trial of Concurrent Chemotherapy and Proton Therapy for Stage III Non-Small Cell Lung Cancer: Results and Reflections Following Early Closure of a Single-Institution Study
International Journal Of Radiation Oncology Biology Physics
2016

Rectal Toxicity After Proton Therapy for Prostate Cancer: An Analysis of Outcomes of Prospective Studies Conducted At the University of Florida Proton Therapy Institute
International Journal Of Radiation Oncology Biology Physics
2015

Proton Therapy to the Subdiaphragmatic Region in the Management of Patients With Hodgkin Lymphoma
Leukemia & Lymphoma
2015

Proton Therapy in the Management of Non-Hodgkin Lymphoma
Leukemia & Lymphoma
2015

Hemorrhagic Radiation Cystitis
American Journal of Clinical Oncology-Cancer Clinical Trials
2015

Expert Radiation Oncologist Interpretations of Involved-Site Radiation Therapy Guidelines in the Management of Hodgkin Lymphoma
International Journal Of Radiation Oncology Biology Physics
2015

Acr Appropriateness Criteria (R) Diffuse Large B-Cell Lymphoma
American Journal of Clinical Oncology-Cancer Clinical Trials
2015

Variable Interpretations By Experienced Radiation Oncologists of Involved-Site Radiation Therapy Guidelines for Lymphoma
International Journal Of Radiation Oncology Biology Physics
2014

The Dosimetric Impact of Small Smearing and Ptv Margin Reductions On Dvh Values for Oar in Image Guided Therapy for Localized Prostate Cancer
International Journal Of Radiation Oncology Biology Physics
2014

Testosterone Replacement Therapy in Men With Prostate Cancer After Proton Therapy
Journal of Clinical Oncology
2014

Sbrt/Srs Experience Using a Vero Linac for Oligometastases
International Journal Of Radiation Oncology Biology Physics
2014

Proton Therapy in the Management of Lymphoma
Cancer Journal
2014

Proton Therapy in the Management of High-Risk Prostate Cancer
International Journal Of Radiation Oncology Biology Physics
2014

Proton Therapy for Prostate Cancer: An Analysis of Rectal Toxicity Outcomes At University of Florida Proton Therapy Institute (Ufpti).
Journal of Clinical Oncology
2014

Proton Therapy for Hodgkin Lymphoma
Current Hematologic Malignancy Reports
2014

Patient-Reported Sexual Outcomes and Potency Following Proton Therapy for the Management of Prostate Cancer.
Journal of Clinical Oncology
2014

Management of Radiation Proctitis
American Journal of Clinical Oncology-Cancer Clinical Trials
2014

Impact of Change From Ctcae Version 3 To Ctcae Version 4 On Urologic Toxicity Scores in Prostate Cancer
International Journal Of Radiation Oncology Biology Physics
2014

Impact On Dose To Abdominal Organs With the Use of Proton Therapy in the Management of Diaphragmatic and Infradiaphragmatic Hodgkin Lymphoma
International Journal Of Radiation Oncology Biology Physics
2014

Five-Year Outcomes From 3 Prospective Trials of Image-Guided Proton Therapy for Prostate Cancer
International Journal Of Radiation Oncology Biology Physics
2014

Comparing Patient-Reported Bowel Quality of Life Scores To Physician-Reported Ctcae Bowel Toxicity for Men Treated With High-Dose Image Guided Radiation Therapy for Prostate Cancer
International Journal Of Radiation Oncology Biology Physics
2014

Comparative Effectiveness Study of Patient-Reported Outcomes After Proton Therapy Or Intensity-Modulated Radiotherapy for Prostate Cancer

2014

Acr Appropriateness Criteria Follow-Up of Hodgkin Lymphoma
Journal of the American College of Radiology
2014

Acr Appropriateness Criteria (R) W Pediatric Hodgkin Lymphoma

2014

Urinary Functional Outcomes and Toxicity Five Years After Proton Therapy for Low- and Intermediate-Risk Prostate Cancer: Results of Two Prospective Trials
Acta Oncologica
2013

Pulmonary Toxicity Following Proton Therapy for Patients With Non-Small Cell Lung Cancer
International Journal Of Radiation Oncology Biology Physics
2013

Proton-Based Chemoradiation for Synchronous Bilateral Non-Small-Cell Lung Cancers: a Case Report
Thoracic Cancer
2013

Proton Therapy in a Pediatric Patient With Stage III Hodgkin Lymphoma
Acta Oncologica
2013

Proton Therapy as Salvage Treatment for Local Relapse of Prostate Cancer Following Cryosurgery Or Hifu
International Journal Of Radiation Oncology Biology Physics
2013

Proton Therapy With Concomitant Capecitabine for Pancreatic and Ampullary Cancers Is Associated With a Low Incidence of Gastrointestinal Toxicity
Acta Oncologica
2013

Postoperative Proton Therapy in the Management of Stage III Thymoma
Journal of Thoracic Oncology
2013

Phase 2 Study of Consolidative Involved-Node Proton Therapy in Patients With Hodgkin Lymphoma: Early Outcomes
International Journal Of Radiation Oncology Biology Physics
2013

Patient-Reported Hip Symptoms Following Treatment With Proton Therapy for Prostate Cancer
International Journal Of Radiation Oncology Biology Physics
2013

Outcomes in Men With Large Prostates (>= 60 Cm(3)) Treated With Definitive Proton Therapy for Prostate Cancer
Acta Oncologica
2013

Improving the Therapeutic Ratio By Using Proton Therapy in Patients With Stage I Or II Seminoma
American Journal of Clinical Oncology-Cancer Clinical Trials
2013

Hypofractionated Passively Scattered Proton Radiotherapy for Low- and Intermediate-Risk Prostate Cancer Is Not Associated With Post-Treatment Testosterone Suppression
Acta Oncologica
2013

Hip Fractures and Pain Following Proton Therapy for Management of Prostate Cancer
Acta Oncologica
2013

Grade 3 Genitourinary Toxicities in Men After Proton Therapy for Prostate Cancer
International Journal Of Radiation Oncology Biology Physics
2013

Five-Year Outcomes of Proton Therapy in Localized Prostate Cancer On 3 Prospective Trials for Low-, Intermediate-, and High-Risk Prostate Cancer
International Journal Of Radiation Oncology Biology Physics
2013

Early Gastrointestinal Toxicity Outcomes From a Prospective Trial of Accelerated Hypofractionation With Proton Therapy for Prostate Cancer
International Journal Of Radiation Oncology Biology Physics
2013

Dosimetric Rationale and Early Experience At Ufpti of Thoracic Proton Therapy and Chemotherapy in Limited-Stage Small Cell Lung Cancer
Acta Oncologica
2013

Comparative Effectiveness Study of Proton Therapy Versus Imrt for Definitive Treatment of Prostate Cancer Based On Patient-Reported Outcomes
International Journal Of Radiation Oncology Biology Physics
2013

Androgen Deprivation Therapy and Definitive Radiotherapy for Prostate Cancer
American Journal of Clinical Oncology-Cancer Clinical Trials
2013

Acr Appropriateness Criteria (R) Localized Nodal Indolent Lymphoma
Oncology-New York
2013

Three-Year Analysis of Urinary Toxicity in 2 Prospective Trials of Image Guided Proton Therapy for Early- and Intermediate-Risk Prostate Cancer: Outcomes in Men With Moderate To Severe Pretreatment Urinary Obstructive Symptoms
International Journal Of Radiation Oncology Biology Physics
2012

The Value of Dose Constraints in Minimizing Rectal Toxicity in Patients Receiving Radiation Therapy for Prostate Cancer: Three-Year Analysis of Toxicity Outcomes in 2 Prospective Trials of Image Guided Proton Therapy for Early- and Intermediate-Risk Prostate Cancer
International Journal Of Radiation Oncology Biology Physics
2012

Selective Nodal Irradiation of Regionally Advanced Non-Small-Cell Lung Cancer With Proton Therapy and Imrt: a Dosimetric Comparison
Thoracic Cancer
2012

Protons Offer Reduced Normal-Tissue Exposure for Patients Receiving Postoperative Radiotherapy for Resected Pancreatic Head Cancer
International Journal Of Radiation Oncology Biology Physics
2012

Proton Therapy for Pancreatic Cancer - Toxicity Data and Early Outcomes
Pancreas
2012

Proton Therapy for Lung Cancer
Thoracic Cancer
2012

Proton Therapy With Concurrent Chemotherapy for Non-Small-Cell Lung Cancer: Technique and Early Results
Clinical Lung Cancer
2012

Proton Therapy May Allow Elective Nodal Coverage in the Setting of Neoadjuvant Radiation Therapy for Pancreatic Head Cancers Without Significantly Increasing Normal Tissue Exposure
International Journal Of Radiation Oncology Biology Physics
2012

Proton Radiotherapy for Prostate Cancer Is Not Associated With Post-Treatment Testosterone Suppression
International Journal Of Radiation Oncology Biology Physics
2012

Patient-Reported Quality of Life Following Treatment of Prostate Cancer With Proton Therapy
International Journal Of Radiation Oncology Biology Physics
2012

Outcomes of Patients With Non-Hodgkin'S Lymphoma Treated With Bexxar With Or Without External-Beam Radiotherapy
International Journal Of Radiation Oncology Biology Physics
2012

Improving the Therapeutic Ratio in Hodgkin Lymphoma Through the Use of Proton Therapy
Oncology
2012

Impact of Proton Therapy To the Prostate Alone Versus the Whole Pelvis On Patient-Reported Outcomes and Toxicities in High-Risk Prostate Cancer Patients
International Journal Of Radiation Oncology Biology Physics
2012

Hypofractionated Proton Radiation Therapy for Low- And, Intermediate-Risk Prostate Cancer Is Not Associated With Post-Treatment Testosterone Suppression
International Journal Of Radiation Oncology Biology Physics
2012

Erectile Function, Incontinence, and Other Quality of Life Outcomes Following Proton Therapy for Prostate Cancer in Men 60 Years Old and Younger

2012

Effective Dose Reduction To Cardiac Structures Using Protons Compared With 3Dcrt and Imrt in Mediastinal Hodgkin Lymphoma
International Journal Of Radiation Oncology Biology Physics
2012

Early Patterns of Failure in a Prospective Trial of Concomitant Docetaxel and Proton Therapy for High-Risk Prostate Cancer
International Journal Of Radiation Oncology Biology Physics
2012

Early Outcomes From Three Prospective Trials of Image-Guided Proton Therapy for Prostate Cancer
International Journal Of Radiation Oncology Biology Physics
2012

Does Race Influence Quality of Life, Toxicity, Or Early Relapse Following Proton Therapy in Men With Prostate Cancer?
International Journal Of Radiation Oncology Biology Physics
2012

Consolidative Involved-Node Proton Therapy for Stage Ia-Iiib Mediastinal Hodgkin Lymphoma: Preliminary Dosimetric Outcomes From a Phase Ii Study
International Journal Of Radiation Oncology Biology Physics
2012

Advantages of Proton Therapy in the Management of Primary Mediastinal B-Cell Lymphoma (Pmbcl)
British Journal of Haematology
2012

Reduction of Prostate Intrafraction Motion Using Gas-Release Rectal Balloons
International Journal Of Radiation Oncology Biology Physics
2011

Reducing the Dose To the Cardiac Chambers, Valves, and Vessels With Proton Therapy Compared With 3D-Crt and Imrt in Patients With Mediastinal Hodgkin Lymphoma
International Journal Of Radiation Oncology Biology Physics
2011

Protons Safely Allow Coverage of High-Risk Nodes for Patients With Regionally Advanced Non-Small-Cell Lung Cancer
Technology in Cancer Research & Treatment
2011

Proton Therapy in Craniopharyngioma: New Opportunity for Minimizing Radiation Sequelae
International Journal Of Radiation Oncology Biology Physics
2011

Proton Therapy for Prostate Cancer
Oncology
2011

Proton Radiation Therapy Offers Reduced Normal Lung and Bone Marrow Exposure for Patients Receiving Dose-Escalated Radiation Therapy for Unresectable Stage III Non-Small-Cell Lung Cancer: a Dosimetric Study
Clinical Lung Cancer
2011

Patient-Reported Sexual Function Following Proton Therapy for Prostate Cancer in Men Age <= 60 Years
International Journal Of Radiation Oncology Biology Physics
2011

Outcomes in Men With Large Prostates (>= 60 G) Treated With Definitive Proton Therapy for Prostate Cancer
International Journal Of Radiation Oncology Biology Physics
2011

Image-Guided Proton Therapy for Low- and Intermediate-Risk Prostate Cancer: Three-Year Results of Two Prospective Trials
International Journal Of Radiation Oncology Biology Physics
2011

Early Outcomes for Pancreatic Cancer Patients Treated With Proton Therapy
International Journal Of Radiation Oncology Biology Physics
2011

Dosimetric Advantage of Proton Therapy in Adolescents With Hodgkin Lymphoma Involving the Mediastinum

2011

Technique and Early Outcomes of Proton Therapy With Concurrent Chemotherapy for Lung Cancer
Journal of Thoracic Oncology
2010

Risk of Hip and Femoral Neck Fractures Following Proton Therapy for Prostate Cancer
International Journal Of Radiation Oncology Biology Physics
2010

Protons Offer Reduced Normal Tissue Exposure for Patients Receiving Postoperative Radiotherapy (Rt) for Resected Pancreatic Head Cancer
International Journal Of Radiation Oncology Biology Physics
2010

Is There a Role for Proton Therapy After High-Intensity Focused Ultrasound and Cryosurgery Failures in Prostate Cancer?
International Journal Of Radiation Oncology Biology Physics
2010

Early Outcomes Following Proton Therapy for Prostate Cancer in Men 55 Years Old and Younger
International Journal Of Radiation Oncology Biology Physics
2010

Double-Scattered Proton-Based Stereotactic Body Radiotherapy for Stage I Lung Cancer: a Dosimetric Comparison With Photon-Based Stereotactic Body Radiotherapy
Radiotherapy and Oncology
2010

Proton Therapy for Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
2009

Proton Radiotherapy for Prostate Cancer Is Not Associated With Post Treatment Testosterone Suppression
International Journal Of Radiation Oncology Biology Physics
2009

In Regard To Hoppe Et Al. (Int J Radiat Oncol Biol Phys 2008;72:1283-1286) Reply
International Journal Of Radiation Oncology Biology Physics
2009

Early Gi and Gu Toxicity in Three Prospective Trials of Proton Therapy for Prostate Cancer
International Journal Of Radiation Oncology Biology Physics
2009

Dosimetric Comparison of Photon-Based and Proton-Based Stereotactic Body Radiotherapy for Stage I Non-Small Cell Lung Cancer
International Journal Of Radiation Oncology Biology Physics
2009